149 related articles for article (PubMed ID: 29961080)
1. CAR-T in the clinic: drive with care.
Yáñez-Muñoz RJ; Grupp SA
Gene Ther; 2018 Jun; 25(3):157-161. PubMed ID: 29961080
[No Abstract] [Full Text] [Related]
2. CAR T-cell therapy: perceived need versus actual evidence.
The Lancet Oncology
Lancet Oncol; 2018 Oct; 19(10):1259. PubMed ID: 30303110
[No Abstract] [Full Text] [Related]
3. CAR-T: trailblazing the path from clinical development to the clinic.
Butera S
Gene Ther; 2018 Jun; 25(3):163-164. PubMed ID: 29686331
[No Abstract] [Full Text] [Related]
4. Immunotherapy: Tisagenlecleucel - the first approved CAR-T-cell therapy: implications for payers and policy makers.
Prasad V
Nat Rev Clin Oncol; 2018 Jan; 15(1):11-12. PubMed ID: 28975930
[No Abstract] [Full Text] [Related]
5. Functional design of chimeric T-cell antigen receptors for adoptive immunotherapy of cancer: architecture and outcomes.
Shirasu N; Kuroki M
Anticancer Res; 2012 Jun; 32(6):2377-83. PubMed ID: 22641678
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-armed chimeric antigen receptor-modified T cells for cancer immunotherapy.
Huang Y; Li D; Qin DY; Gou HF; Wei W; Wang YS; Wei YQ; Wang W
Gene Ther; 2018 Jun; 25(3):192-197. PubMed ID: 28820501
[TBL] [Abstract][Full Text] [Related]
7. [CAR-T cell development and other gene therapy: Everything is not so easy].
Dalle JH; Baudoux E; Caillat-Zucman S; Colledani F; Pereira M; Bruno B; Nguyen S; Robin M; Rubio MT; Bay JO
Bull Cancer; 2020 Apr; 107(4):408-409. PubMed ID: 32334675
[No Abstract] [Full Text] [Related]
8. The revving up of CARs.
Abid MB
Gene Ther; 2018 Jun; 25(3):162. PubMed ID: 29654247
[No Abstract] [Full Text] [Related]
9. CAR T Cell Therapy for Solid Tumors.
Newick K; O'Brien S; Moon E; Albelda SM
Annu Rev Med; 2017 Jan; 68():139-152. PubMed ID: 27860544
[TBL] [Abstract][Full Text] [Related]
10. Driving cars to the clinic for solid tumors.
Castellarin M; Watanabe K; June CH; Kloss CC; Posey AD
Gene Ther; 2018 Jun; 25(3):165-175. PubMed ID: 29880908
[TBL] [Abstract][Full Text] [Related]
11. CAR-T field booms as next-generation platforms attract big players.
Morrison C
Nat Biotechnol; 2015 Jun; 33(6):571-2. PubMed ID: 26057954
[No Abstract] [Full Text] [Related]
12. Driving CARs on the Highway to Solid Cancer: Some Considerations on the Adoptive Therapy with CAR T Cells.
Abken H
Hum Gene Ther; 2017 Nov; 28(11):1047-1060. PubMed ID: 28810803
[TBL] [Abstract][Full Text] [Related]
13. Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models.
Mata M; Gerken C; Nguyen P; Krenciute G; Spencer DM; Gottschalk S
Cancer Discov; 2017 Nov; 7(11):1306-1319. PubMed ID: 28801306
[TBL] [Abstract][Full Text] [Related]
14. From the guest editor: The rise of CAR therapy: the CD19 paradigm, and beyond. Introduction.
Sadelain M
Cancer J; 2014; 20(2):105-6. PubMed ID: 24667953
[No Abstract] [Full Text] [Related]
15. Armed T cells with CAR for cancer immunotherapy.
Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):331-2. PubMed ID: 27080712
[No Abstract] [Full Text] [Related]
16. Chimeric antigen receptor T-cell therapies for lymphoma.
Brudno JN; Kochenderfer JN
Nat Rev Clin Oncol; 2018 Jan; 15(1):31-46. PubMed ID: 28857075
[TBL] [Abstract][Full Text] [Related]
17. Sending CAR T Cells After Multiple Myeloma.
Cancer Discov; 2017 Aug; 7(8):OF9. PubMed ID: 28588060
[TBL] [Abstract][Full Text] [Related]
18. Chimeric Antigen Receptor T-Cells: New Approaches to Improve Their Efficacy and Reduce Toxicity.
Maus MV; Powell DJ
Cancer J; 2015; 21(6):475-9. PubMed ID: 26588679
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.
Chen KH; Wada M; Firor AE; Pinz KG; Jares A; Liu H; Salman H; Golightly M; Lan F; Jiang X; Ma Y
Oncotarget; 2016 Aug; 7(35):56219-56232. PubMed ID: 27494836
[TBL] [Abstract][Full Text] [Related]
20. Establishing guidelines for CAR-T cells: challenges and considerations.
Wang W; Qin DY; Zhang BL; Wei W; Wang YS; Wei YQ
Sci China Life Sci; 2016 Apr; 59(4):333-9. PubMed ID: 26965523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
